Advice
Regulatory information
Regulatory information
Caris Molecular Intelligence (CMI) was CE marked as an in vitro diagnostic medical device in 2015.
A search of the Medicines and Healthcare products Regulatory Agency website revealed that no manufacturer field safety notices or medical device alerts have been issued for this technology.